Argentum Pharmaceuticals, LLC v. Alcon Research, Ltd. > Summary
Court Case Number IPR2016-00544
Filing Date Feb 2, 2016
Institution Decision Date Jul 18, 2016
Decision Date Nov 30, 2016
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesChristopher M. Kaiser, Christopher G. Paulraj, Jennifer Meyer Chagnon
Judge Writing the Final DecisionChristopher M. Kaiser
Claims Challenged in the Petition: 1, 2, 3, 4, 8, 12, 13, 21, 22
Claims Instituted: 1, 2, 3, 4, 8, 12, 13, 21, 22
Petitioner
Patent Owner
Petitioner Attorneys
5Argentum Pharmaceuticals
Attorney Name: Deborah H. Yellin
Crowell & Moring
Argentum Pharmaceuticals
Attorney Name: Teresa Stanek Rea
Crowell & Moring
Argentum Pharmaceuticals
Attorney Name: Joseph P. Meara
Foley & Lardner LLP
Argentum Pharmaceuticals
Attorney Name: Michael R. Houston
Foley & Lardner LLP
Patent Owner Attorneys
7Alcon Research
Attorney Name: Thomas S. Fletcher
Williams & Connolly
Alcon Research
Attorney Name: David M. Krinsky
Williams & Connolly
Alcon Research
Attorney Name: Christopher J. Mandernach
Williams & Connolly
Alcon Research
Attorney Name: Thomas H.l. Selby
Williams & Connolly
Alcon Research
Attorney Name: Adam L. Perlman
Williams & Connolly
Alcon Research
Attorney Name: Thomas S. Fletcher
Williams & Connolly
Alcon Research
Attorney Name: David M. Krinsky
Williams & Connolly
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08791154 | High concentration olopatadine ophthalmic composition | Jul 29, 2014 |
